Skip to main content
Top
Published in: BMC Geriatrics 1/2017

Open Access 01-12-2017 | Research Article

The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older

Authors: Birthe A. Lehmann, Renske Eilers, Liesbeth Mollema, José Ferreira, Hester E. de Melker

Published in: BMC Geriatrics | Issue 1/2017

Login to get access

Abstract

Background

Increasing life expectancy results in a larger proportion of older people susceptible to vaccine preventable diseases (VPDs). In the Netherlands, influenza vaccination is routinely offered to people aged 60 years and older. Vaccination against pneumococcal disease, herpes zoster and pertussis is rarely used. These vaccines will be evaluated by the Dutch Health Council and might be routinely offered to older people in the near future. Possible expansion of the program depends partly on the willingness of general practitioners (GPs) to endorse additional vaccinations. In this study, we assessed predictors of GPs’ attitude and intention to vaccinate people aged 60 years and older.

Methods

GPs (N = 12.194) were invited to fill in an online questionnaire consisting of questions about social cognitive factors that can influence the willingness of GPs to vaccinate people aged 60 years and older, including underlying beliefs, practical considerations of adding more vaccines to the national program, demographics, and GPs’ patient population characteristics. The questionnaire was filled in by 732 GPs.

Results

GPs were positive both about vaccination as a preventive tool and the influenza vaccination program, but somewhat less positive about expanding the current program. Prediction analysis showed that the intention of GPs to offer additional vaccination was predicted by their attitude towards offering additional vaccination, towards vaccination as a preventive tool, towards offering vaccination during an outbreak and on GPs opinion regarding suitability to offer additional vaccination (R2 = 0.60). The attitude of GPs towards offering additional vaccination was predicted by the perceived severity of herpes zoster and pneumonia, as well as the perceived incidence of herpes zoster. Severity of diseases was ranked as important argument to recommend vaccination, followed by effectiveness and health benefits of vaccines.

Conclusion

Providing GPs with evidence-based information about the severity and prevalence of diseases, and effectiveness and health benefits of the vaccines, together with an active role of GPs in informing older people about vaccines, could modify the intention towards additional vaccination of people 60 years and older.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mathei C, Vaes B, Wallemacq P, Dedryse J. Association between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL cohort. J Am Geriatr Soc. 2011;59:2201–8.CrossRefPubMed Mathei C, Vaes B, Wallemacq P, Dedryse J. Association between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL cohort. J Am Geriatr Soc. 2011;59:2201–8.CrossRefPubMed
4.
go back to reference Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 2000;30(6):931–3.CrossRefPubMed Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 2000;30(6):931–3.CrossRefPubMed
5.
go back to reference Bijkerk P, van Lier EA, van Vliet JA, Kretzschmar ME. [Dutch] Effecten van vergrijzing op infectieziekten [Effects of ageing on infectious disease]. Ned Tijdschr Geneeskd. 2010;154:A1613.PubMed Bijkerk P, van Lier EA, van Vliet JA, Kretzschmar ME. [Dutch] Effecten van vergrijzing op infectieziekten [Effects of ageing on infectious disease]. Ned Tijdschr Geneeskd. 2010;154:A1613.PubMed
6.
go back to reference De Boer AH. [Dutch] Rapportage Ouderen 2006: veranderingen in de leefsituatie en levensloop. Den Haag: Sociaal en Cultureel Planbureau; 2006. De Boer AH. [Dutch] Rapportage Ouderen 2006: veranderingen in de leefsituatie en levensloop. Den Haag: Sociaal en Cultureel Planbureau; 2006.
7.
go back to reference Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4(1):26–33.CrossRefPubMed Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4(1):26–33.CrossRefPubMed
9.
go back to reference Eilers R, Krabbe PF, van Essen TG, Suijkerbuijk A, van Lier A, de Melker HE. Assessment of vaccine candidates for persons aged 50 and older: a review. BMC Geriatr. 2013;13(1):32.CrossRefPubMedPubMedCentral Eilers R, Krabbe PF, van Essen TG, Suijkerbuijk A, van Lier A, de Melker HE. Assessment of vaccine candidates for persons aged 50 and older: a review. BMC Geriatr. 2013;13(1):32.CrossRefPubMedPubMedCentral
11.
go back to reference Eilers R, Krabbe PF, de Melker HE. Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study. BMC Public Health. 2015;15:493.CrossRefPubMedPubMedCentral Eilers R, Krabbe PF, de Melker HE. Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study. BMC Public Health. 2015;15:493.CrossRefPubMedPubMedCentral
14.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.
15.
go back to reference Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002;2/3. Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002;2/3.
16.
go back to reference van Hassel DTP, Kasteleijn A, Kenens RJ. Records from the general practitioners’ registration poll of 2014 [Dutch]: Netherlands Institute for Health Services Research; 2015. van Hassel DTP, Kasteleijn A, Kenens RJ. Records from the general practitioners’ registration poll of 2014 [Dutch]: Netherlands Institute for Health Services Research; 2015.
17.
go back to reference Nichol KL, Zimmerman R. Generalist and subspecialist physicians’ knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients. Arch Intern Med. 2001;161(22):2702–8.CrossRefPubMed Nichol KL, Zimmerman R. Generalist and subspecialist physicians’ knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients. Arch Intern Med. 2001;161(22):2702–8.CrossRefPubMed
18.
go back to reference Szilagyi PG, Shone LP, Barth R, Kouides RW, Long C, Humiston SG, et al. Physician practices and attitudes regarding adult immunizations. Prev Med. 2005;40(2):152–61.CrossRefPubMed Szilagyi PG, Shone LP, Barth R, Kouides RW, Long C, Humiston SG, et al. Physician practices and attitudes regarding adult immunizations. Prev Med. 2005;40(2):152–61.CrossRefPubMed
19.
go back to reference Pavia M, Foresta MR, Carbone V, Angelillo IF. Influenza and pneumococcal immunization in the elderly: knowledge, attitudes, and practices among general practitioners in Italy. Public Health. 2003;117(3):202–7.CrossRefPubMed Pavia M, Foresta MR, Carbone V, Angelillo IF. Influenza and pneumococcal immunization in the elderly: knowledge, attitudes, and practices among general practitioners in Italy. Public Health. 2003;117(3):202–7.CrossRefPubMed
20.
go back to reference Ridda I, Lindley IR, Gao Z, McIntyre P, MacIntyre CR. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine. 2008;26:5633–40.CrossRefPubMed Ridda I, Lindley IR, Gao Z, McIntyre P, MacIntyre CR. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine. 2008;26:5633–40.CrossRefPubMed
21.
go back to reference Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010;152:555–60. PMID: 20439573 CrossRefPubMed Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010;152:555–60. PMID: 20439573 CrossRefPubMed
22.
go back to reference Hurley LP, Harpaz R, Daley MF, Crane LA, Beaty BL, Barrow J, et al. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis. 2008;197(Suppl 2):S216–23.CrossRefPubMed Hurley LP, Harpaz R, Daley MF, Crane LA, Beaty BL, Barrow J, et al. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis. 2008;197(Suppl 2):S216–23.CrossRefPubMed
24.
go back to reference European Centre for Disease Prevention and Control (ECDC). Implementation of the Council recommendation on seasonal influenza vaccination. Stockholm; 2014. European Centre for Disease Prevention and Control (ECDC). Implementation of the Council recommendation on seasonal influenza vaccination. Stockholm; 2014.
25.
go back to reference Hershey CO, Karuza J. Delivery of vaccines to adults: correlations with physician knowledge and patient variables. Am J Med Qual. 1997;12:143–50.CrossRefPubMed Hershey CO, Karuza J. Delivery of vaccines to adults: correlations with physician knowledge and patient variables. Am J Med Qual. 1997;12:143–50.CrossRefPubMed
26.
go back to reference Santoli JM, Peter G, Arvin AM, Davis JP, Decker MD, Fast P, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA. 2003;290:3122.CrossRefPubMed Santoli JM, Peter G, Arvin AM, Davis JP, Decker MD, Fast P, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA. 2003;290:3122.CrossRefPubMed
27.
go back to reference Merkel PA, Caputo GC. Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate. J Gen Intern Med. 1994;9:679–83.CrossRefPubMed Merkel PA, Caputo GC. Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate. J Gen Intern Med. 1994;9:679–83.CrossRefPubMed
28.
go back to reference Zimmerman RK, Silverman M, Janosky JE, Mieczkowski TA, Wilson SA, Bardella IJ, et al. A comprehensive investigation of barriers to adult immunization: a methods paper. J Fam Pract. 2001;50:703.PubMed Zimmerman RK, Silverman M, Janosky JE, Mieczkowski TA, Wilson SA, Bardella IJ, et al. A comprehensive investigation of barriers to adult immunization: a methods paper. J Fam Pract. 2001;50:703.PubMed
29.
go back to reference Drociuk D. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations – United States, 1996. MMWR Morb Mortal Wkly Rep. 1999;48:556–890. Drociuk D. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations – United States, 1996. MMWR Morb Mortal Wkly Rep. 1999;48:556–890.
30.
go back to reference Santibanez TA, Nowalk MP, Zimmerman RK, Jewell IK, Bardella IJ, Wilson SA, et al. Knowledge and beliefs about influenza, pneumococcal disease, and immunizations among older people. J Am Geriatr Soc. 2002;50:1711–6.CrossRefPubMed Santibanez TA, Nowalk MP, Zimmerman RK, Jewell IK, Bardella IJ, Wilson SA, et al. Knowledge and beliefs about influenza, pneumococcal disease, and immunizations among older people. J Am Geriatr Soc. 2002;50:1711–6.CrossRefPubMed
31.
32.
go back to reference Opstelten W, Hak E, Verheij TJM, van Essen GA. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance. Am J Med. 2001;111:474–9.CrossRefPubMed Opstelten W, Hak E, Verheij TJM, van Essen GA. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance. Am J Med. 2001;111:474–9.CrossRefPubMed
33.
go back to reference Zimmerman RK, Santibanez TA, Janosky JE, Fine MJ, Raymund M, Wilson SA, et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and veterans affairs practices. Am J Med. 2003;114:31–8.CrossRefPubMed Zimmerman RK, Santibanez TA, Janosky JE, Fine MJ, Raymund M, Wilson SA, et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and veterans affairs practices. Am J Med. 2003;114:31–8.CrossRefPubMed
34.
go back to reference Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71–9.CrossRefPubMed Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71–9.CrossRefPubMed
35.
go back to reference Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis. 2000;19(11):834–42.CrossRefPubMed Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis. 2000;19(11):834–42.CrossRefPubMed
Metadata
Title
The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older
Authors
Birthe A. Lehmann
Renske Eilers
Liesbeth Mollema
José Ferreira
Hester E. de Melker
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2017
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-017-0511-7

Other articles of this Issue 1/2017

BMC Geriatrics 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.